Table 1 Clinicopathologic patient characteristics (n = 130)
Clinicopathologic characteristics | N (%) | |
|---|---|---|
Age (years) | ≥40 | 86 (66.1%) |
<40 | 44 (33.9%) | |
Clinical tumor size (cT) | 1 | 7 (5.4%) |
2 | 98 (75.4%) | |
3 | 24 (18.4%) | |
4 | 1 (0.8%) | |
Clinical nodal status (cN) | Negative | 56 (43.1%) |
Positive | 74 (56.9%) | |
Stage | II | 105 (80.8%) |
III | 25 (19.2%) | |
pCR status | pCR | 44 (33.9%) |
Non-pCR | 86 (66.1%) | |
Neoadjuvant ICIs | Yes | 7 (5.4%) |
No | 123 (94.6%) | |
Ki67 | <20 | 5 (3.9%) |
20–50 | 31 (23.9%) | |
>50 | 85 (65.3%) | |
NA | 9 (6.9%) | |
Miller–Payne Grading | 1–3 | 38 (29.2%) |
4–5 | 71 (54.6%) | |
NA | 21 (16.2%) | |
